Implantable Cardioverter-Defibrillators
7
0
0
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
14.3%
1 terminated out of 7 trials
80.0%
-6.5% vs benchmark
14%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Ertugliflozin to Reduce Arrhythmic Burden in ICD/CRT patientS (ERASe-Trial) - a Phase III Study
Defibrillation Testing During Implantable Cardioverter Defibrillator (ICD) Replacement
Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead
Deactivation of Implantable Cardioverter Defibrillator During Non-thoracic Surgical Procedures
Enhancing Knowledge Implantable Cardioverter-Defibrillators (ICDs)
Internet-based Intervention in Cardioverter-defibrillator Patients to Enhance Quality of Life
Benefits of Implantable Cardioverter Defibrillator Follow-up Using Remote Monitoring